Niki BioSolutions, Inc. (NIKI) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Niki BioSolutions, Inc. (NIKI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $561,915, listed on NASDAQ, employing roughly 1 people, carrying a beta of 0.17 to the broader market. Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. Led by Chung Yuen Huen, public since 2026-07-20.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for NIKI as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →